BIA 6-512
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for BIA 6-512, covering 2017-03-27 to 2017-03-31. Get the full timeline:
Most recent: Clinical Trial Update: Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics With a Single-dose of Levodopa/Benserazide 200/50 mg or With a Single-dose of Levodopa/Benserazide 200/50 mg Plus a Single-dose of Nebicapone 150 mg [Phase 1]